Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
P.1.13 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.372NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.634NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.37.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.630NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.360NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.578NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.544NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.448NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.425NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.354NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.503NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.623NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.214.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.588NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.210NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.567NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.541NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18513.9US
B.1.189NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.563NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.258NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.426NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.399NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.337NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.539NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.54NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.164NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.392NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.377NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.5.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BB.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.22.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HW.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used